XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Approximation [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022   552,739        
Balance at Dec. 31, 2022   $ 55 $ 122,029,476 $ (242,602) $ (116,485,373) $ 5,301,556
Issuance of common stock for directors’ fees (in shares)   855        
Issuance of common stock for directors’ fees   $ 0 12,002 0   12,002
Issuance of common stock to employees   $ 0 4 0 0 4
Restricted stock forfeited (in shares)   (1,102)        
Restricted stock forfeited   $ (0) 3,105 (0) (0) 3,105
Other comprehensive income (loss) – Foreign currency translation adjustment   0 0 72,146 0 72,146
Share-based compensation   0 62,474 0 0 62,474
Net loss   $ 0 0 0 (1,688,322) (1,688,322)
Issuance of restricted common stock to employees and directors (in shares)   2,222        
Net loss   $ 0 0 0 (1,688,322) (1,688,322)
Balance (in shares) at Mar. 31, 2023   554,714        
Balance at Mar. 31, 2023   $ 55 122,100,851 (170,456) (118,173,695) 3,756,755
Restricted stock forfeited   $ 0 (3,105) 0 0 (3,105)
Balance (in shares) at Dec. 31, 2022   552,739        
Balance at Dec. 31, 2022   $ 55 122,029,476 (242,602) (116,485,373) 5,301,556
Other comprehensive income (loss) – Foreign currency translation adjustment           127,394
Net loss           (6,149,024)
Net loss           (6,149,024)
Balance (in shares) at Sep. 30, 2023   570,026        
Balance at Sep. 30, 2023   $ 57 122,263,999 (115,208) (122,634,397) (485,549)
Balance (in shares) at Mar. 31, 2023   554,714        
Balance at Mar. 31, 2023   $ 55 122,100,851 (170,456) (118,173,695) 3,756,755
Issuance of common stock for directors’ fees (in shares)   1,286        
Issuance of common stock for directors’ fees   $ 0 16,002 0 0 16,002
Restricted stock forfeited (in shares)   (799)        
Other comprehensive income (loss) – Foreign currency translation adjustment   $ 0 0 19,884 0 19,884
Share-based compensation   0 57,831 0 0 57,831
Net loss   $ 0 0 0 (2,622,878) (2,622,878)
Issuance of common stock for Employee stock purchase plan (in shares)   1,557        
Issuance of common stock for Employee stock purchase plan   $ 0 13,934 0 0 13,934
Share based compensation for employee stock plan   0 3,563 0 0 3,563
Net loss   $ 0 0 0 (2,622,878) (2,622,878)
Balance (in shares) at Jun. 30, 2023   556,758        
Balance at Jun. 30, 2023   $ 55 122,192,181 (150,572) (120,796,573) 1,245,091
Restricted stock forfeited   0 0 0 0 0
Restricted stock forfeited   $ 0 0 0 0 0
Issuance of common stock for directors’ fees (in shares)   937        
Issuance of common stock for directors’ fees   $ 0 11,002 0 0 11,002
Issuance of common stock to employees   $ 2 (2) 0 0 0
Restricted stock forfeited (in shares)   (1,852)        
Other comprehensive income (loss) – Foreign currency translation adjustment   $ 0 0 35,364 0 35,364
Share-based compensation   0 60,821 0 0 60,821
Net loss   $ 0 0 0 (1,837,824) (1,837,824)
Issuance of restricted common stock to employees and directors (in shares)   14,183        
Net loss   $ 0 0 0 (1,837,824) (1,837,824)
Balance (in shares) at Sep. 30, 2023   570,026        
Balance at Sep. 30, 2023   $ 57 122,263,999 (115,208) (122,634,397) (485,549)
Restricted stock forfeited   0 (3) 0 0 (3)
Restricted stock forfeited   $ 0 (3) 0 0 (3)
Balance (in shares) at Dec. 31, 2023   1,032,777        
Balance at Dec. 31, 2023   $ 103 126,047,851 22,821 (125,007,210) 1,063,565
Issuance of common stock for directors’ fees (in shares)   4,287        
Issuance of common stock for directors’ fees   $ 0 9,003 0   9,003
Issuance of common stock to employees   $ 0 0 0 0 0
Restricted stock forfeited (in shares)   (316)        
Restricted stock forfeited   $ 0 0 0 0 0
Exercise of warrants (in shares)   777,666        
Exercise of warrants   $ 78 1,322 0 0 1,400
Other comprehensive income (loss) – Foreign currency translation adjustment   0 (62,275) 0 (62,275)
Share-based compensation   0 47,790 0 0 47,790
Issuance costs   0 (13,470) 0 0 (13,470)
Net loss   0 0 0 (510,285) (510,285)
Exercise of warrants   78 1,322 0 0 1,400
Net loss   $ 0 0 0 (510,285) (510,285)
Balance (in shares) at Mar. 31, 2024   1,814,414        
Balance at Mar. 31, 2024   $ 181 126,092,496 (39,454) (125,517,495) 535,728
Restricted stock forfeited   $ 0 0 0 0 0
Balance (in shares) at Dec. 31, 2023   1,032,777        
Balance at Dec. 31, 2023   $ 103 126,047,851 22,821 (125,007,210) 1,063,565
Other comprehensive income (loss) – Foreign currency translation adjustment           51,878
Net loss           (2,916,195)
Net loss           (2,916,195)
Balance (in shares) at Sep. 30, 2024   3,109,288        
Balance at Sep. 30, 2024   $ 311 127,981,436 74,699 (127,923,404) 133,042
Balance (in shares) at Mar. 31, 2024   1,814,414        
Balance at Mar. 31, 2024   $ 181 126,092,496 (39,454) (125,517,495) 535,728
Issuance of common stock for directors’ fees   $ 48,315        
Restricted stock forfeited (in shares)   (186)        
Restricted stock forfeited   $ 0 0 0 0 0
Other comprehensive income (loss) – Foreign currency translation adjustment   0 0 24,220 0 24,220
Share-based compensation    
Net loss $ (1,666,950) $ 0 0 0 (1,666,950)  
Issuance of common stock for Employee stock purchase plan (in shares)   1,390        
Issuance of common stock for Employee stock purchase plan   $ 1 1,938 0 0 1,939
Share based compensation for employee stock plan   0 456 0 0 456
Net loss $ (1,666,950) $ 0 0 0 (1,666,950)  
Balance (in shares) at Jun. 30, 2024   1,815,618        
Balance at Jun. 30, 2024   $ 182 126,143,205 (15,234) (127,184,445) (1,056,292)
Restricted stock forfeited   0 0 0 0 0
Issuance of common stock to employees   $ 17 (17) 0 0 0
Restricted stock forfeited (in shares)   (849)        
Restricted stock forfeited   $ 0 0 0 0 0
Exercise of warrants (in shares)   1,030,556        
Exercise of warrants   $ 103 1,906,425 1,906,528
Other comprehensive income (loss) – Foreign currency translation adjustment   0 0 89,933 0 89,933
Share-based compensation   0 66,053 0 0 66,053
Issuance costs    
Net loss   $ 0 0 0 (738,959) (738,959)
Issuance of restricted common stock to employees and directors (in shares)   168,963        
Exercise of prefunded warrants (in shares)   95,000        
Exercise of prefunded warrants   $ 9 162 171
Exercise of warrants   103 1,906,425 1,906,528
Issuance costs   (134,392)        
Net loss   $ 0 0 0 (738,959) (738,959)
Balance (in shares) at Sep. 30, 2024   3,109,288        
Balance at Sep. 30, 2024   $ 311 127,981,436 74,699 (127,923,404) 133,042
Restricted stock forfeited   $ 0 $ 0 $ 0 $ 0 $ 0